These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1802902)

  • 1. Acquired trichomegaly of the eyelashes: a cutaneous marker of acquired immunodeficiency syndrome.
    Kaplan MH; Sadick NS; Talmor M
    J Am Acad Dermatol; 1991 Nov; 25(5 Pt 1):801-4. PubMed ID: 1802902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired trichomegaly of the eyelashes in a child with human immunodeficiency virus infection.
    Patrizi A; Neri I; Trestini D; Landi C; Ricci G; Masi M
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):89-91. PubMed ID: 9731980
    [No Abstract]   [Full Text] [Related]  

  • 3. [Trichomegaly in HIV infection].
    Daneschfar A; Davis CP; Trüeb RM
    Schweiz Med Wochenschr; 1993 Oct; 123(41):1941-4. PubMed ID: 8259476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired trichomegaly associated with acquired immunodeficiency syndrome.
    Graham DA; Sires BS
    Arch Ophthalmol; 1997 Apr; 115(4):557-8. PubMed ID: 9109774
    [No Abstract]   [Full Text] [Related]  

  • 5. Excessive growth of eyelashes in patients with acquired immunodeficiency syndrome.
    Baccard M; Morel P
    Cutis; 1994 Feb; 53(2):83-4. PubMed ID: 7851127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eyelash length in HIV-infected patients.
    Almagro M; del Pozo J; García-Silva J; Martínez W; Castro A; Fonseca E
    AIDS; 2003 Jul; 17(11):1695-6. PubMed ID: 12853753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitative viremia and p24 antigenemia in short-term follow-up of the treatment with zidovudine in twenty HIV infected patients].
    Tamalet C; Puel J; Fleury H; Ferchal F; Agut H; Brun-Vezinet F; Botti G; Rouzioux C
    Pathol Biol (Paris); 1993 Apr; 41(4):399-403. PubMed ID: 8233642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired eyelash trichomegaly and alopecia areata in a human immunodeficiency virus-infected patient.
    Grossman MC; Cohen PR; Grossman ME
    Dermatology; 1996; 193(1):52-3. PubMed ID: 8864621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired trichomegaly of the eyelashes and hypertrichosis induced by bimatoprost.
    Herane MI; Urbina F
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):644-5. PubMed ID: 15324422
    [No Abstract]   [Full Text] [Related]  

  • 10. [Trichomegaly: an exceptional expression of the acquired immunodeficiency syndrome].
    López Dupla JM; Valencia ME; Pintado V; Khamashta MA
    Med Clin (Barc); 1989 Apr; 92(14):556. PubMed ID: 2755226
    [No Abstract]   [Full Text] [Related]  

  • 11. Acquired trichomegaly in uveitis.
    Bayer A; Bagkesen H; Sobaci G
    Can J Ophthalmol; 2007 Feb; 42(1):101-6. PubMed ID: 17361249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertrichosis of the eyelashes in acquired immunodeficiency syndrome.
    Casanova JM; Puig T; Rubio M
    Arch Dermatol; 1987 Dec; 123(12):1599-601. PubMed ID: 3688901
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum IgD behaviour in HIV-1 infected patients.
    Raiteri R; Albonico M; Deiana R; Marietti G; Sinicco A
    Allergol Immunopathol (Madr); 1991; 19(1):6-10. PubMed ID: 1950942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus (HIV) antigenemia (p24) in the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT).
    Jackson GG; Paul DA; Falk LA; Rubenis M; Despotes JC; Mack D; Knigge M; Emeson EE
    Ann Intern Med; 1988 Feb; 108(2):175-80. PubMed ID: 3124680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zidovudine-interferon-alpha combination therapy in patients with advanced human immunodeficiency virus type 1 infection: biphasic response of p24 antigen and quantitative polymerase chain reaction.
    Edlin BR; Weinstein RA; Whaling SM; Ou CY; Connolly PJ; Moore JL; Bitran JD
    J Infect Dis; 1992 May; 165(5):793-8. PubMed ID: 1349031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children.
    Luzuriaga K; Koup RA; Pikora CA; Brettler DB; Sullivan JL
    J Pediatr; 1991 Aug; 119(2):230-6. PubMed ID: 1907319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular side effects and trichomegaly of eyelashes induced by erlotinib: a case report and review of the literature.
    Celik T; Kosker M
    Cont Lens Anterior Eye; 2015 Feb; 38(1):59-60. PubMed ID: 25249292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstitution of long-term T helper cell function after zidovudine therapy in human immunodeficiency virus-infected patients.
    Clerici M; Landay AL; Kessler HA; Phair JP; Venzon DJ; Hendrix CW; Lucey DR; Shearer GM
    J Infect Dis; 1992 Oct; 166(4):723-30. PubMed ID: 1388195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired trichomegaly: trichomegaly secondary to erlotinib.
    Medina Mendez CA; Ma PC; Singh AD
    JAMA Ophthalmol; 2014 Sep; 132(9):1051. PubMed ID: 25078467
    [No Abstract]   [Full Text] [Related]  

  • 20. Eyelash trichomegaly: review of congenital, acquired, and drug-associated etiologies for elongation of the eyelashes.
    Paul LJ; Cohen PR; Kurzrock R
    Int J Dermatol; 2012 Jun; 51(6):631-46; quiz 643-4, 646. PubMed ID: 22607279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.